Tagged with strategy

Switzerland Jean-François Gouzer, CEO of Scientis Pharma, discusses the company’s origin story, its specialization in skin pigmentation disorders, and future internationalization prospects Could you start by introducing the Scientis Pharma story and how the company was founded? “Switzerland is a great environment to do business and to create and develop a…

India A pioneer of the biotechnology industry in India and the head of the country’s leading biotechnology enterprise, Kiran Mazumdar-Shaw, discusses the recent US FDA approval of Ogivri™, the first biosimilar for trastuzumab and the sixth approved biosimilar in the US overall, and how Biocon is implementing a low-value high-volume model…

Switzerland Jeff Dufour, country manager Switzerland and BU lead Internal Medicine at Pfizer, discusses his first impressions of the country, his priorities for greater dialogue with Swiss healthcare insurers, and Switzerland’s potential as a ‘test market’ for the company. Can you give our international readers an outline of your background and…

Serbia Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the West Balkan region, and the company’s dedication to providing unique and efficient solutions for diabetes and concomitant complications. Could you…

Canada Dr. Jean-Yves Leroux, CEO and founder of Medelys, lets his entrepreneurial fiber shine through in this interview as he talks about the beginnings of his company in 2006, the initial challenges, and the prospects for collagen-based natural health products in the treatment of joint pain resulting from arthritis and osteoporosis…

Switzerland Ryad Dahmani, CEO of Swiss-headquartered cold chain logistics specialists, Cold Chain Vision, discusses the impact of new technology in the logistics industry, the importance of quality controls in the transportation of vaccines and why Cold Chain Vision is a name worth remembering for the future. Could you please start by…

Canada Mark Nawacki, CEO and co-founder of Searchlight Pharma, affirms the company’s dedication to women’s health through a modern approach to current market trends. He underlines the company’s commitment to productive collaborations with healthcare professionals and industry partners and its aspiration to bring life-changing innovations to Canadian patients. Mark, can you…

Switzerland Stefan Frefel, CEO of Bilfinger Industrial Services in Switzerland, outlines Bilfinger’s core offering of maintenance and engineering services to the pharmaceutical industry, the importance of the Swiss affiliate to the global group, and how the company is positioning itself at the forefront of digital disruption and other new industry trends.…

Austria Albin Egger, country representative of UCB Pharma Austria, discusses the strong performance of the Austrian affiliate within the global group, organizational restructuring, and the receptiveness of Austria to UCB’s innovative products. Globally, UCB registered nine percent growth for the first nine months of 2017. How would you describe the contribution…

Canada Linda Tibbits, general manager at Pierre Fabre Dermo-Cosmetics in Canada takes us back to the beginnings of the French company in the country, where its initial success was driven by the harmonic relationship between Pierre Fabre himself and Jean Coutu, founder of Canada’s largest pharmacy network. She further talks portfolio…

India With the Indian public healthcare apparatus straining at the seams to provide affordable access to treatments to the country’s vast population, two pioneering pharmaceutical multinationals – Novartis and Janssen – have stepped up with innovative initiatives to fill the gaps. “Economists such as Michael Porter see Arogya Parivar as a…

Serbia Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into the pharmaceutical powerhouse that we see today. In this interview in the newly renovated offices in Belgrade, Seeliger sheds light…